NT$
68.70
May 22
Business Description
Bionime Corp
NAICS : 541711
SIC : 8731
ISIN : TW0004737002
Description
Financial Strength
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.14 | |||||
Equity-to-Asset | 0.36 | |||||
Debt-to-Equity | 1.46 | |||||
Debt-to-EBITDA | 14.63 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 1.06 | |||||
Beneish M-Score | -2.25 | |||||
WACC vs ROIC |
Growth Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 1.2 | |||||
3-Year EBITDA Growth Rate | -6.4 | |||||
3-Year FCF Growth Rate | -43.8 | |||||
3-Year Book Growth Rate | -1.9 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 33.63 | |||||
9-Day RSI | 41.34 | |||||
14-Day RSI | 44.01 | |||||
6-1 Month Momentum % | -11.97 | |||||
12-1 Month Momentum % | -13.42 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.82 | |||||
Quick Ratio | 0.56 | |||||
Cash Ratio | 0.21 | |||||
Days Inventory | 182.64 | |||||
Days Sales Outstanding | 93.54 | |||||
Days Payable | 49.64 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 3.03 | |||||
Dividend Payout Ratio | 19.09 | |||||
3-Year Dividend Growth Rate | 1.8 | |||||
Forward Dividend Yield % | 3.03 | |||||
5-Year Yield-on-Cost % | 1.87 | |||||
3-Year Average Share Buyback Ratio | -0.6 | |||||
Shareholder Yield % | -6.22 |
Profitability Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 41.17 | |||||
Operating Margin % | -1.99 | |||||
Net Margin % | 0.38 | |||||
FCF Margin % | -16.87 | |||||
ROE % | 0.35 | |||||
ROA % | 0.13 | |||||
ROIC % | 0.17 | |||||
ROC (Joel Greenblatt) % | 0.69 | |||||
ROCE % | 0.67 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 624.54 | |||||
Shiller PE Ratio | 34.09 | |||||
PS Ratio | 2.32 | |||||
PB Ratio | 2.19 | |||||
Price-to-Tangible-Book | 3.4 | |||||
Price-to-Operating-Cash-Flow | 43.56 | |||||
EV-to-EBIT | 279.9 | |||||
EV-to-EBITDA | 34.56 | |||||
EV-to-Revenue | 3.62 | |||||
EV-to-FCF | -21.52 | |||||
Price-to-Projected-FCF | 3.93 | |||||
Price-to-Median-PS-Value | 1.17 | |||||
Earnings Yield (Greenblatt) % | 0.36 | |||||
FCF Yield % | -7.3 | |||||
Forward Rate of Return (Yacktman) % | -10.66 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Bionime Corp Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil NT$) | 1,808.917 | ||
EPS (TTM) (NT$) | 0.11 | ||
Beta | 0.39 | ||
Volatility % | 14.97 | ||
14-Day RSI | 44.01 | ||
14-Day ATR (NT$) | 1.023242 | ||
20-Day SMA (NT$) | 69.435 | ||
12-1 Month Momentum % | -13.42 | ||
52-Week Range (NT$) | 67.2 - 90.1 | ||
Shares Outstanding (Mil) | 60.82 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Bionime Corp Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Bionime Corp Stock Events
Event | Date | Price(NT$) | ||
---|---|---|---|---|
No Event Data |
Bionime Corp Frequently Asked Questions
What is Bionime Corp(TPE:4737)'s stock price today?
When is next earnings date of Bionime Corp(TPE:4737)?
Does Bionime Corp(TPE:4737) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |